Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Post-Surgery Temozolomide in Newly Diagnosed GBM
NCT00686725Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2008
- Primary completion
- Sep 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of temozolomide in glioblastoma multiforme (GBM), sponsored by Merck & Co.. Started Jun 2008; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00686725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686725.